CustomerInsights.AI (CIAI) and Ikigai Labs Collaborate to Develop Cutting-Edge AI Solutions for the Pharmaceutical Industry
Tuesday, July 23, 2024
CustomerInsights.AI (CIAI) is excited to announce a new partnership with Ikigai Labs to explore the use of advanced Generative AI (GenAI) in the pharmaceutical industry. This collaboration aims to address key challenges, including sales forecasting, call routing, resource management, fraud detection in pharmacies, and large-scale data matching.
The partnership will integrate CIAI's ciPARTHENON™ Commercial Analytics Cloud, which includes over 40 specialized applications, with Ikigai's innovative large graphical model (LGM) platform. Together, they will develop scalable AI solutions tailored to the needs of the pharmaceutical sector.
CustomerInsights.AI, stated, "This partnership with Ikigai Labs presents exciting opportunities. By combining our AI technologies, we aim to revolutionize Life Sciences data and analytics, driving meaningful advancements in the industry. The potential of GenAI for structured data is immense, especially with the wealth of syndicated datasets available in Pharma."
Kamal Ahluwalia, President of Ikigai Labs, added, "Our collaboration with CIAI aligns perfectly with our goal to maximize the value of tabular and time series data. Our AI technology specializes in learning and interpreting patterns within customer data securely, making it well-suited for enterprise applications. This partnership will enhance demand forecasting, inventory management, and workforce planning, offering significant cost savings and operational efficiencies."
This alliance between CustomerInsights.AI and Ikigai Labs reflects their commitment to developing cutting-edge AI solutions for the pharmaceutical industry. The initial phase of the partnership will involve working with industry leaders on projects focused on operational excellence and achieving impactful results.
Source: prnewswire.com
